Last reviewed · How we verify
NCT03552510: OPAMM
Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility
NA trial testing Oro-pharyngeal Administration of Mother's Milk in Preterm Infant in 20 participants. Completed in 30 December 2018.
30 December 2018
Quick facts
| Lead sponsor | Mansoura University Children Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 20 |
| Start date | 1 June 2016 |
| Primary completion | 30 December 2018 |
| Estimated completion | 30 December 2018 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Oro-pharyngeal Administration of Mother's Milk
Conditions studied
- Preterm Infant — all drugs for Preterm Infant →
- Feeding Disorder Neonatal — all drugs for Feeding Disorder Neonatal →
- Gastrointestinal Motility Disorder — all drugs for Gastrointestinal Motility Disorder →
Sponsor
Mansoura University Children Hospital
Who can join
Adults 1 Day to 60 Days, any sex, with Preterm Infant or Feeding Disorder Neonatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mother's milk does not come in contact with the oropharyngeal pouch of preterm infants during gavage feeding. We hypothesized that stimulation of the oropharyngeal pouch using small amount of the mother's milk 5 minutes before initiation of regular gavage feeding will increase the level of GIT hormones.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03552510
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preterm Infant
Currently open trials in the same condition.
- NCT06786039 — Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants · recruiting
- NCT06532695 — Development, ADL, Participation, and Quality of Life in Preterm Infants: Longitudinal Research · recruiting
- NCT07238231 — Taiwan Preterm Infant Database: Analysis and Comparison of Birth Conditions and Exploration of Prognostic Factors · active not recruiting
- NCT03518736 — Does Timing Matter? Supporting Play, Exploration, and Early Developmental Intervention · NA · active not recruiting
- NCT03373721 — Gut Microbiota of Preterm Infants and Full-term Infants at Early Life · recruiting
Other Mansoura University Children Hospital trials
Trials by the same sponsor.
- NCT05589909 — Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis · unknown
- NCT04474327 — Role of Montelukast in Modulation of Response to Sepsis in Preterm Infants · Phase 1 · completed
- NCT03731611 — Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency · NA · completed
- NCT05091008 — Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children · Phase 2 · completed
- NCT05596656 — IgE-mediated Allergies Among Type 1 Diabetes Mellitus Children, Single Centre Observational Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03552510 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University Children Hospital
- Last refreshed: 15 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03552510.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing